SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Staar Surgical -- know anything about it?
STAA 26.54-0.3%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Terrence Von Holidae who wrote (82)5/11/1997 7:28:00 PM
From: m meixlER   of 133
 
I agree the price to sales is high----What is it with some of these
biotechs with no sales or earnings----some of the large caps like Ko
and CSCO are 6-7X sales---the market has put a premium on staa with
a high PE and relitively high mkt cap because of the potential--the
two products developing in staa's pipeline address large markets--from
the co's 96 annual report:

the glaucoma wick--wordwide demand for the device est 200-400 million
the icl addresses a US 1 billion market

i dont think the investing public and or institutions realize the potential
of the icl---it is literally taking legally blind folks and giving them 20/20
vision.. The ceo stated this would be a 120 million in sales co by the
year 2000.--with gross margins higher than they are today.
97 as a year in tranistion to new products will be a good year to
accumualte more. MM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext